The Polyphenols α-Mangostin and Nordihydroguaiaretic Acid Induce Oxidative Stress, Cell Cycle Arrest, and Apoptosis in a Cellular Model of Medulloblastoma.
Alberto Rojas-OchoaEmilio J CórdovaAdela Carrillo-GarcíaMarcela LizanoPedraza-Chaverri JoséNelly PatiñoAlfredo Cruz-GregorioNorma OsnayaPublished in: Molecules (Basel, Switzerland) (2021)
Medulloblastoma is a common malignant brain tumor in the pediatric age. The current therapeutics present serious collateral effects. Polyphenols α-mangostin and nordihydroguaiaretic acid (NDGA) exert potent antitumoral activity in different cancer models, although their antitumoral effects have not been described in medulloblastoma cells yet. This study aimed to examine the proapoptotic effects of these polyphenols on human medulloblastoma cells. Medulloblastoma cell line Daoy was incubated with increasing concentrations of α-mangostin or NDGA for 24 h. The cell viability was analyzed using crystal violet and trypan blue dyes. Determination of the glutathione (GSH)/glutathione disulfide (GSSG) ratio and levels of carbonylated proteins was performed to evaluate the oxidative stress. Cell cycle progression and induction of cell death by fluorochrome-couple and TUNEL assays were evaluated using flow cytometry assays. Individual treatments with α-mangostin or NDGA decreased the viability of Daoy cells in a dose-dependent manner, inducing G2/M and S-G2/M cell cycle arrest, respectively. Both polyphenols induced cell death and increased oxidative stress. Very interestingly, α-mangostin showed more potent effects than NDGA. Our results indicate that α-mangostin and NDGA exert important cytostatic and cytotoxic effects in the Daoy cell line. These data highlight the potential usefulness of these compounds as an alternative strategy in medulloblastoma treatment.
Keyphrases
- cell cycle arrest
- cell death
- pi k akt
- oxidative stress
- cell cycle
- induced apoptosis
- diabetic rats
- cell proliferation
- signaling pathway
- endothelial cells
- dna damage
- small molecule
- ischemia reperfusion injury
- risk assessment
- squamous cell carcinoma
- artificial intelligence
- electronic health record
- papillary thyroid
- climate change
- mass spectrometry
- induced pluripotent stem cells
- combination therapy
- replacement therapy